Medical/Pharmaceuticals
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SYDNEY, July 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the Phas...
2023-07-24 21:02
1823
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept
BRIDGEWATER, N.J. and BENGALURU, India, July 24, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion r...
2023-07-24 18:30
1662
Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership
Apollo performs the highest number of solid organ transplants in the world per year NEW DELHI, July 24, 2023 /PRNewswire/ -- Apollo, the world's largest vertically integrated healthcare provider, has achieved a momentous feat by completing 23,000 transplants. The Apollo Transplant Program stands...
2023-07-24 14:30
1742
Project Matty: Revolutionizing Care for Children with Autism and ADHD Through AI
SINGAPORE, July 24, 2023 /PRNewswire/ -- Project Matty, a pioneering digital health solution, has been launched by a dedicated mother of an ADHD-diagnosed child and Dr.Pamela Lim, a clinical psychology doctor. Both inspired by their personal experiences and united by their commitment to improve t...
2023-07-24 12:11
2636
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....
2023-07-24 10:30
2574
ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization Offering in Australia
The expanded agreement allows providers to locally acquire TeraRecon's solutions CAMBRIDGE, Mass., July 24, 2023 /PRNewswire/ -- Advanced visualization and AI leader TeraRecon, a ConcertAI company, is excited to announce an expansion of its reseller and service agreement inAustralia with Change H...
2023-07-24 04:30
2058
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
SUZHOU, China, July 22, 2023 /PRNewswire/ -- Last month, the American Society
for Artificial Internal Organs (ASAIO) 68th Annual Meeting
2023-07-22 18:17
6462
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
SUZHOU, China, July 22, 2023 /PRNewswire/ -- Last month, the American Society
for Artificial Internal Organs (ASAIO) 68th Annual Meeting
2023-07-22 17:50
2432
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
SHANGHAI, July 21, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 7MW3711 for advanced malignant solid tumor was approved by the National Medical Products Administration (NMPA). 7MW3711...
2023-07-22 00:00
4454
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * If approved by the European Commission, ORSERDU would be the first an...
2023-07-21 23:44
5737
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979
NANJING, China, July 21, 2023 /PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharmaceutical company in immunocytokines with full-set of capabilities from discovery to commercialization, announced that IBB0979 (B7H3-IL10 immunocytokine), a potential first...
2023-07-21 22:51
2973
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...
2023-07-21 18:00
2899
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent
* Striving to further expand its territory to Africa and the Middle East from Southeast Asia and Latin America * "Will create synergy between international procurement market and private markets of individual countries so as to boost sales and profitability" YONGIN, South Korea, July 21, 2023...
2023-07-21 16:47
2028
Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference
BEIJING and SHANGHAI and BOSTON, July 20, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, is pleased to announce today that the company will present its clinical results in the form of Proffered Paper presentation at the 2023 Europ...
2023-07-21 10:19
1922
Saphnelo now available in Malaysia as an add-on treatment for adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE)
KUALA LUMPUR, Malaysia, July 21, 2023 /PRNewswire/ -- AstraZeneca's Saphnelo ( anifrolumab) has now become available as add-on treatment for adult patients in Malaysia with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE) following insufficient response to sta...
2023-07-21 10:00
2386
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer
SEONGNAM, South Korea, July 20, 2023 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onJuly 19 that the US FDA had granted an orphan drug designation for small cell lung cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development. SNB-101 is the world...
2023-07-21 08:15
1926
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK0100...
2023-07-21 08:00
2957
ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
AMSTERDAM, July 20, 2023 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference® (AAIC®) 2023 covered the breadth of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk f...
2023-07-20 21:01
2661
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research a...
2023-07-20 19:15
2431
PolyU awarded RGC Strategic Topics Grant to address societal needs in mental healthcare
HONG KONG, July 20, 2023 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has received funding support from the Strategic Topics Grant (STG) 2023/24 of the Research Grants Council (RGC) for a health technology project aimed at promoting a new paradigm shift with creation of an integra...
2023-07-20 19:07
2193
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
Agoda releases generative AI film to capture the joy of travel
2024-12-10 10:00
3697
Blokees' Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
2024-12-08 00:23
3553
Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
2024-12-09 10:00
3473